Tech Company Financing Transactions
A&G Pharmaceutical Funding Round
On 3/24/2004, A&G Pharmaceutical raised $750 thousand in funding from New England Partners.
Transaction Overview
Company Name
Announced On
3/24/2004
Transaction Type
Debt
Amount
$750,000
Round
Undisclosed
Investors
Proceeds Purpose
A&G intends to use the net proceeds from the convertible note coupled with an SBIR grant from the National Cancer Institute to support ongoing clinical and research and development efforts on the Company's serum diagnostic kit for breast cancer
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9130 Red Branch Rd. U
Columbia, MD 21045
USA
Columbia, MD 21045
USA
Phone
Website
Email Address
Overview
A&G Pharmaceutical is a theranostics company developing therapeutic and diagnostic products for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ginette Serrero
VP - R & D
Jun Hayashi
Browse more venture capital transactions:
Prev: 3/24/2004: RNT venture capital transaction
Next: 3/29/2004: Cobalt venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs